Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction
Authors
Keywords
-
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-05-21
DOI
10.1245/s10434-023-13643-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma
- (2022) Sivesh Kathir Kamarajah et al. ANNALS OF SURGERY
- Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis
- (2021) Patrick Sven Plum et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Neo-AEGIS (Neoadjuvant trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study): Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy (Modified MAGIC or FLOT protocol). (NCT01726452).
- (2021) John V. Reynolds et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival after neoadjuvant approaches to gastroesophageal junction cancer
- (2019) Michael Xiang et al. Gastric Cancer
- A Population-based Study on Lymph Node Retrieval in Patients with Esophageal Cancer: Results from the Dutch Upper Gastrointestinal Cancer Audit
- (2018) L. R. van der Werf et al. ANNALS OF SURGICAL ONCOLOGY
- Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approaches
- (2018) Michael Davidson et al. Expert Review of Anticancer Therapy
- Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta-analysis
- (2018) Kelvin K. W. Chan et al. INTERNATIONAL JOURNAL OF CANCER
- Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus
- (2018) Els Visser et al. JOURNAL OF SURGICAL ONCOLOGY
- Prognosis of patients with superficial T1 esophageal cancer who underwent endoscopic resection before esophagectomy—A propensity score-matched comparison
- (2018) Patrick Sven Plum et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Neoadjuvant chemoradiotherapy or chemotherapy for gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis
- (2018) Fausto Petrelli et al. Gastric Cancer
- Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial
- (2017) Michael Stahl et al. EUROPEAN JOURNAL OF CANCER
- Worldwide incidence, mortality and time trends for cancer of the oesophagus
- (2017) Bhawna Gupta et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal or GEJ adenocarcinoma: A propensity score-matched analysis comparing toxicity, pathologic outcome, and survival
- (2017) Lucas Goense et al. JOURNAL OF SURGICAL ONCOLOGY
- Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer
- (2017) Thomas W. Rice et al. Journal of Thoracic Oncology
- Oesophageal cancer
- (2017) Jesper Lagergren et al. LANCET
- Neoadjuvant treatment of locally advanced esophageal and junctional cancer: the evidence-base, current key questions and clinical trials
- (2017) Claire L. Donohoe et al. Journal of Thoracic Disease
- Multimodality treatment for esophageal adenocaricnoma: multi-center propensity-score matched study
- (2016) S. R. Markar et al. ANNALS OF ONCOLOGY
- A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction
- (2016) F. Klevebro et al. ANNALS OF ONCOLOGY
- ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)
- (2016) Jens Hoeppner et al. BMC CANCER
- No Survival Difference with Neoadjuvant Chemoradiotherapy Compared with Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: Results from the National Cancer Data Base
- (2016) Eisar Al-Sukhni et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients
- (2016) Pamela Samson et al. Journal of Thoracic Oncology
- Epidemiology of Barrett’s Esophagus and Esophageal Adenocarcinoma
- (2015) Thomas M. Runge et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Survival after neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis
- (2015) Mengying Fan et al. Thoracic Cancer
- Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma
- (2014) Michael S Landau et al. MODERN PATHOLOGY
- Esophageal Carcinoma
- (2014) Anil K. Rustgi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Budding in Upper Gastrointestinal Carcinomas
- (2014) Viktor H. Koelzer et al. Frontiers in Oncology
- Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
- (2012) P. van Hagen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Impact of Upper, Middle, and Lower Third Mucosal or Submucosal Infiltration in Early Esophageal Cancer
- (2011) Arnulf H. Hölscher et al. ANNALS OF SURGERY
- Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction
- (2009) Michael Stahl et al. JOURNAL OF CLINICAL ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started